3/3
11:11 am
ions
Rating for IONS
Low
Report
Rating for IONS
2/26
09:31 am
ions
Rating for IONS
Low
Report
Rating for IONS
2/26
06:16 am
ions
Rating for IONS
Low
Report
Rating for IONS
2/26
06:16 am
ions
Rating for IONS
Low
Report
Rating for IONS
2/25
03:58 pm
ions
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by Needham & Company LLC.
Low
Report
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by Needham & Company LLC.
2/25
03:58 pm
ions
Ionis Pharmaceuticals (IONS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
Ionis Pharmaceuticals (IONS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
2/25
03:58 pm
ions
Ionis Pharmaceuticals (IONS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
Ionis Pharmaceuticals (IONS) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
1/28
08:03 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $95.00 price target on the stock.
1/5
01:43 pm
ions
Rating for IONS
Low
Report
Rating for IONS
1/5
01:43 pm
ions
Rating for IONS
Low
Report
Rating for IONS
1/5
08:42 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/17
10:01 am
ions
Rating for IONS
Low
Report
Rating for IONS
12/17
10:01 am
ions
Rating for IONS
Low
Report
Rating for IONS
12/17
07:06 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/17
07:06 am
ions
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Ionis Pharmaceuticals (NASDAQ:IONS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
12/15
03:44 pm
ions
Rating for IONS
Low
Report
Rating for IONS